| CAS ID: | 111025-46-8 |
| Molecular Formula: | C19H20N2O3S |
| Molecular Weight: | 356.5 g/mol |
| Monoisotopic Mass: | 356.1195 g/mol |
| Class: | Small Molecule |
| Natural Product: | No |
| Other Names: | GLIZOFAR | U-72107A | PIOGLITAZONE | GLIDIPION | PIOGLITAZONE HYDROCHLORIDE | Actos | Duetact | DIABIOM |
| Analysis: | Drug repositioning mechanism analysis |
Reference Record 1
| PubMed ID | 23633075 | Target ID | |
| Uniprot ID | Name | ||
| Model | vitro,rat | Fibrosis Disease | Cardiac fibrosis |
| Process I | |||
| Process II | |||
| Process III | |||
| Mechanism | Targeting miR-711-SP1 | ||
Reference Record 2
| PubMed ID | 21127991 | Target ID | T0526 |
| Uniprot ID | Peroxisome proliferator-activated receptor gamma | Name | Peroxisome proliferator-activated receptor gamma |
| Model | vitro | Fibrosis Disease | Corneal fibrosis |
| Process I | |||
| Process II | cells proliferation,myofibroblasts differentiation | ||
| Process III | prevenet collagen deposition | ||
| Mechanism | Targeting TGFβ | ||
Reference Record 3
Reference Record 4
Reference Record 5
Reference Record 6
Reference Record 7
| PubMed ID | 24161914 | Target ID | |
| Uniprot ID | Name | ||
| Model | rat | Fibrosis Disease | Pulmonary fibrosis |
| Process I | |||
| Process II | fibroblasts accumulation | ||
| Process III | prevenet collagen deposition | ||
| Mechanism | |||
Trial Record 1
| ClinicalTrial ID | NCT00719381 | Disease | Cystic fibrosis |
| Phase | Phase 1 | Status | Completed |
| First Received | July 21, 2008 | Last Verified | June 14, 2012 |
| Sponsor | Paul Beringer | ||
Trial Record 2
| ClinicalTrial ID | NCT00322868 | Disease | Cystic fibrosis |
| Phase | Not Applicable | Status | Completed |
| First Received | May 8, 2006 | Last Verified | February 23, 2018 |
| Sponsor | University Hospitals Cleveland Medical Center | ||
Trial Record 3
| ClinicalTrial ID | NCT00531882 | Disease | Cystic fibrosis |
| Phase | Not Applicable | Status | Completed |
| First Received | September 19, 2007 | Last Verified | October 5, 2017 |
| Sponsor | University Hospitals Cleveland Medical Center | ||
Trial Record 4
| ClinicalTrial ID | NCT00570622 | Disease | Liver fibrosis |
| Phase | Phase 4 | Status | Completed |
| First Received | December 11, 2007 | Last Verified | November 25, 2008 |
| Sponsor | Medical University of Vienna | ||